This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
The peptide treatment serum and supporting regimen produced statistically significant reductions in facial and eye wrinkles both at rest and during maximum smile, along with improvements in skin smoothness, softness, firmness, radiance, and overall appearance after 14 weeks of use.
Why it matters
This study supports the potential of peptide-based topical treatments to improve visible signs of skin aging, which is important for developing effective anti-aging skincare products.
How the study worked
An open-label, single-center clinical usage study was conducted over 14 weeks involving 29 women with mild to moderate photodamaged facial skin. Expert investigators assessed facial lines and wrinkles at rest and maximum smile, supplemented by participant self-assessments.
What this study cannot tell us
The study was open-label without a placebo control group, and the sample size was relatively small, which may limit the generalizability of the findings.
Read the original research
An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.
Journal of drugs in dermatology : JDD, 15(9), 1100-6
Citation
Draelos, Zoe Diana; Kononov, Tatiana; Fox, Theresa. (2016). An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.. Journal of drugs in dermatology : JDD, 15(9), 1100-6.